Newly updated research shows incredible promise, but it's still just the beginning of the era of real cancer therapies.
In part due to research by two University of Michigan researchers, a form of leukemia can be treated more easily through an FDA-approved drug.
CURE sat down with Dr. Tanja A. Gruber of Stanford Medicine Children’s Health to discuss clinical trials in infant leukemia. Recent advancements have brought optimism when it comes to treating infant ...
A small group of patients with an otherwise incurable form of T‑cell leukemia have seen their cancer driven into remission by ...
WICHITA, Kan. (KWCH) - Kansas children battling leukemia have a new hope for survival thanks to a new treatment available in Wichita. KU School of Medicine-Wichita Doctors Nathan Hall and Brian Pate ...
An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with ...
A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.
Forskolin, a plant-derived compound, shows surprising potential against one of the most aggressive forms of leukemia.
While early, study results presented at ASH show Tern’s drug could surpass Novartis’ Scemblix and “raise the bar in efficacy” for chronic myeloid leukemia medicines, the company’s CEO said.
15don MSN
Continuous and fixed-duration treatments result in similar outcomes for chronic lymphocytic leukemia
According to a new trial, patients with chronic lymphocytic leukemia (CLL) show comparable outcomes whether they receive a single-agent treatment indefinitely or a combination treatment for a fixed ...
Nearly one-third of families of children receiving chemotherapy for acute lymphoblastic leukemia (ALL) develop serious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results